179 related articles for article (PubMed ID: 1282961)
1. Effects of endothelin-1 and inhibition of nitric oxide production with NG-monomethyl-L-arginine on arterial pressure and regional blood flow in anesthetized rats.
Takahashi H; Nakanishi T; Nishimura M; Tanaka H; Yoshimura M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S176-8. PubMed ID: 1282961
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.
Izuta M; Clavier N; Kirsch JR; Traystman RJ
Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167
[TBL] [Abstract][Full Text] [Related]
3. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.
Filep JG; Földes-Filep E; Rousseau A; Sirois P; Fournier A
Br J Pharmacol; 1993 Nov; 110(3):1213-21. PubMed ID: 8298811
[TBL] [Abstract][Full Text] [Related]
4. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of L-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats.
Uchida Y; Tsukahara F; Irie K; Nomoto T; Muraki T
Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):188-93. PubMed ID: 8170502
[TBL] [Abstract][Full Text] [Related]
6. Effects of NG-monomethyl-L-arginine, indomethacin, and aspirin on the vasodepressor response to low doses of endothelin-1 and endothelin-3 in rats.
Taniguchi I; Kageyama S; Aihara K; Isogai Y
Jpn Circ J; 1994 Jan; 58(1):69-75. PubMed ID: 8139094
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Drexler H; Hablawetz E; Lu W; Riede U; Christes A
Circulation; 1992 Jul; 86(1):255-62. PubMed ID: 1617777
[TBL] [Abstract][Full Text] [Related]
8. NG-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats.
Gardiner SM; Compton AM; Bennett T; Palmer RM; Moncada S
Eur J Pharmacol; 1989 Nov; 171(2-3):237-40. PubMed ID: 2695339
[TBL] [Abstract][Full Text] [Related]
9. Venoconstriction to endothelin-1 in humans is attenuated by local generation of prostacyclin but not nitric oxide.
Webb DJ; Haynes WG
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S317-20. PubMed ID: 7509975
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
Bedarida GV; Kim D; Blaschke TF; Hoffman BB
Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
[TBL] [Abstract][Full Text] [Related]
11. Renal actions of endothelin-1 and endothelin-3: interactions with the prostaglandin system and nitric oxide.
Chou SY; Porush JG
Am J Kidney Dis; 1995 Jul; 26(1):116-23. PubMed ID: 7541937
[TBL] [Abstract][Full Text] [Related]
12. Effect of NG-monomethyl-L-arginine on regional vascular resistance in rats.
Nakamura T; Sakamaki T; Sato K; Ono Z; Prewitt RL
Jpn Heart J; 1994 May; 35(3):363-8. PubMed ID: 7933552
[TBL] [Abstract][Full Text] [Related]
13. Marked regional heterogeneity in the magnitude of EDRF/NO-mediated vascular tone in awake rats.
Greenblatt EP; Loeb AL; Longnecker DE
J Cardiovasc Pharmacol; 1993 Feb; 21(2):235-40. PubMed ID: 7679157
[TBL] [Abstract][Full Text] [Related]
14. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent circulatory control--a mechanism for the differing peripheral vascular effects of isoflurane versus halothane.
Greenblatt EP; Loeb AL; Longnecker DE
Anesthesiology; 1992 Dec; 77(6):1178-85. PubMed ID: 1466468
[TBL] [Abstract][Full Text] [Related]
16. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.
Richard V; Berdeaux A; la Rochelle CD; Giudicelli JF
Br J Pharmacol; 1991 Sep; 104(1):59-64. PubMed ID: 1786519
[TBL] [Abstract][Full Text] [Related]
17. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
Fryburg DA
J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 May; 109(1):222-8. PubMed ID: 7684304
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nitric oxide formation by guanidines.
Hasan K; Heesen BJ; Corbett JA; McDaniel ML; Chang K; Allison W; Wolffenbuttel BH; Williamson JR; Tilton RG
Eur J Pharmacol; 1993 Nov; 249(1):101-6. PubMed ID: 7506664
[TBL] [Abstract][Full Text] [Related]
20. Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion.
Pique JM; Esplugues JV; Whittle BJ
Gastroenterology; 1992 Jan; 102(1):168-74. PubMed ID: 1727750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
